| |
| |
|
| Insider
Information: |
Intrexon Corp |
| Relationship: |
10% Owner |
| City: |
Germantown |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
139,513 |
|
|
Indirect Shares
|
36,745,755 |
|
|
| Direct
Value |
$23,522 |
|
|
|
Indirect Value
|
$4,022,536 |
|
|
| Total
Shares |
36,885,268 |
|
|
| Total
Value |
$4,046,058 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alaunos Therapeutics |
TCRT |
10% Owner |
2016-12-30 |
139,513 |
2016-12-30 |
9,570,094 |
Premium* |
|
|
Oragenics Inc |
OGEN |
10% Owner |
|
0 |
2016-06-30 |
15,481,644 |
Premium* |
|
|
Fibrocell Science Inc |
FCSC |
10% Owner |
|
0 |
2019-12-13 |
0 |
Premium* |
|
|
Theriva Biologics Ord Shs |
TOVX |
10% Owner |
|
0 |
2019-04-03 |
165,332 |
Premium* |
|
|
Soligenix Inc Common |
SNGX |
10% Owner |
|
0 |
2017-05-08 |
85,397 |
Premium* |
|
|
Armata Pharmaceuticals, Inc |
ARMP |
10% Owner |
|
0 |
2016-12-29 |
674,169 |
Premium* |
|
|
Ocugen Ord Shs |
OCGN |
10% Owner |
|
0 |
2019-01-15 |
1,692,366 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
|
0 |
2018-10-25 |
9,076,753 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TOVX |
Theriva Biologics Ord Shs |
10% Owner |
– – • |
2012-10-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,675,768 |
|
- |
|
| TOVX |
Theriva Biologics Ord Shs |
10% Owner |
– – • |
2012-10-29 |
4 |
B |
$1.60 |
$5,000,000 |
I/I |
3,125,000 |
3,125,000 |
1.5 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
10% Owner |
– – • |
2013-12-17 |
4 |
B |
$1.00 |
$2,500,000 |
I/I |
2,500,000 |
8,675,768 |
1.5 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
10% Owner |
– – • |
2015-09-02 |
4 |
B |
$3.20 |
$3,000,000 |
I/I |
937,500 |
9,613,268 |
1.5 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
10% Owner |
– – • |
2019-04-01 |
4 |
S |
$0.67 |
$27,924 |
I/I |
(41,678) |
244,402 |
0 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
10% Owner |
– – • |
2019-04-02 |
4 |
S |
$0.66 |
$9,006 |
I/I |
(13,646) |
234,493 |
0 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
10% Owner |
– – • |
2019-04-03 |
4 |
S |
$0.65 |
$61,907 |
I/I |
(95,241) |
165,332 |
0 |
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2013-06-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,367,816 |
|
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2017-05-04 |
4 |
S |
$2.97 |
$241,629 |
I/I |
(63,892) |
101,171 |
0 |
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2017-05-04 |
4 |
OE |
$0.80 |
$200,000 |
I/I |
250,000 |
583,334 |
0 |
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2017-05-05 |
4 |
S |
$2.70 |
$230,850 |
I/I |
(85,500) |
87,278 |
0 |
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2017-05-08 |
4 |
S |
$2.54 |
$29,403 |
I/I |
(11,576) |
85,397 |
0 |
- |
|
| OGEN |
Oragenics Inc |
10% Owner |
– – • |
2012-06-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,392,425 |
|
- |
|
| OGEN |
Oragenics Inc |
10% Owner |
– – • |
2012-07-31 |
4 |
B |
$1.50 |
$1,286,333 |
I/I |
857,555 |
857,555 |
1.5 |
- |
|
| OGEN |
Oragenics Inc |
10% Owner |
– – • |
2013-09-30 |
4 |
B |
$3.00 |
$7,945,530 |
I/I |
2,648,510 |
7,040,935 |
1.5 |
- |
|
| OGEN |
Oragenics Inc |
10% Owner |
– – • |
2013-11-20 |
4 |
B |
$2.50 |
$3,106,225 |
I/I |
1,242,490 |
8,140,425 |
1.5 |
- |
|
| OGEN |
Oragenics Inc |
10% Owner |
– – • |
2013-12-18 |
4 |
OE |
$2.82 |
$1,969,040 |
I/I |
698,241 |
8,838,666 |
0 |
- |
|
| OGEN |
Oragenics Inc |
10% Owner |
– – • |
2015-12-01 |
4 |
OE |
$1.50 |
$5,071,506 |
I/I |
3,381,004 |
12,219,670 |
0 |
- |
|
| OGEN |
Oragenics Inc |
10% Owner |
– – • |
2016-06-30 |
4 |
B |
$0.52 |
$1,166,666 |
I/I |
2,261,419 |
14,481,089 |
1.5 |
- |
|
| OCGN |
Ocugen Ord Shs |
10% Owner |
– – • |
2014-12-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,690,570 |
|
- |
|
| OCGN |
Ocugen Ord Shs |
10% Owner |
– – • |
2019-01-11 |
4 |
S |
$0.17 |
$42,806 |
I/I |
(251,800) |
2,438,770 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
10% Owner |
– – • |
2019-01-14 |
4 |
S |
$0.16 |
$64,081 |
I/I |
(400,507) |
2,038,263 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
10% Owner |
– – • |
2019-01-15 |
4 |
S |
$0.15 |
$51,885 |
I/I |
(345,897) |
1,692,366 |
0 |
- |
|
| FCSC |
Fibrocell Science Inc |
10% Owner |
– – • |
2012-10-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
232,938,000 |
|
- |
|
| FCSC |
Fibrocell Science Inc |
10% Owner |
– – • |
2013-07-26 |
4 |
B |
$6.03 |
$7,499,999 |
I/I |
1,243,781 |
2,561,301 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
